LEO 39652 cream

DRUG2 trials

Sponsors

LEO Pharma

Conditions

Atopic Dermatitis

Phase 1

Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream

CompletedNCT01850849

LEO PharmaAtopic Dermatitis

Start: 2013-05-31End: 2014-12-31Updated: 2025-02-24

Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

CompletedNCT02219633

LEO PharmaAtopic Dermatitis

Start: 2014-07-31End: 2015-01-31Updated: 2025-02-24